Cognizant(US:CTSH)2025-07-30 21:00Financial Performance - Revenue for Q2 2025 was $5245 million, an increase of 81% year-over-year as reported, or 72% in constant currency[4, 5] - GAAP diluted EPS for Q2 2025 was $131, compared to $114 in Q2 2024[7] - Adjusted diluted EPS for Q2 2025 was $131, compared to $117 in Q2 2024[7] - GAAP operating margin for Q2 2025 was 156%, compared to 146% in Q2 2024[9] - Adjusted operating margin for Q2 2025 was 156%, compared to 152% in Q2 2024[9] - Operating cash flow for Q2 2025 was $398 million, compared to $262 million in Q2 2024[11] - Free cash flow for Q2 2025 was $331 million, compared to $183 million in Q2 2024[11] Segment and Geographic Performance - Products & Resources segment revenue increased by 160% year-over-year, or 147% in constant currency[17] - Health Sciences segment revenue increased by 62% year-over-year, or 53% in constant currency[17] - Financial Services segment revenue increased by 69% year-over-year, or 60% in constant currency[17] - Communications, Media & Technology segment revenue increased by 31% year-over-year, or 22% in constant currency[17] - North America revenue increased by 96% year-over-year, Europe revenue increased by 47% year-over-year, and Rest of World revenue increased by 81% year-over-year[17] Acquisitions and Bookings - Revenue from the Belcan acquisition contributed approximately 400 basis points to year-over-year growth in Q2 2025[12, 14] - Trailing twelve-month bookings increased 6% year-over-year to $278 billion, representing a book-to-bill ratio of 14x[44] Guidance - Full-year 2025 revenue is projected to be between $207 billion and $211 billion, representing a 40% to 60% increase in constant currency[49]